This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Endologix's CEO Presents At Oppenheimer 22nd Annual Healthcare Conference - Event Transcript

Stocks in this article: ELGX

This is the market, it's about $1 billion global market, the blue slice of the pie represents the United States, clearly the largest segment and this just for aneurysms below the renal arteries and the importance of that anatomy will become clear as I take you through the pipeline.

Here is the competitive set, it's truly us in three other companies, two of which are private, Gore and Cook and Medtronic. As you will see all of those devices which fall into a category called proximal fixation rely upon a similar methodology where the device is inserted through a catheter, implanted and deployed and anchors into the aortic wall with a series of hooks and barbs are attachments to attach itself and hang from the area just below the renal arteries.

Our devices you can see over on the left is just fundamentally different. We have a single piece bifurcated system that actually sits right on the patients bifurcation where the aortis splits up and goes down the leg. Instead of attaching via hooks and barbs up near the renal arteries, we sit on that natural junction where the aortis splits up that’s where we get our platform and our foundation, our stability. And then we add a second piece of just to get seal below the renal arteries.

This unique approach offers patient the advantage to preserve that bifurcation for future peripheral cross-over procedures. So, any one of the other devices once you put that in, you have now lost the ability to do a future peripheral intervention, in a cross-over way with ours we preserve the bifurcation and enable patients to have that opportunity which is important because about a third of AAA patients also have PAD. So, that’s really one of the key distinguishing features of our system and has helped fuel our growth, which as highlighted here you can see we have grown nicely over the last several years, 83 million is the mid-point of our recently increased guidance.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs